Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Vanda Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 1, 2018


WASHINGTON, July 17, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will release results for the second quarter of 2018 on Wednesday, August 1, 2018, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, August 1, 2018, during which management will discuss the second quarter 2018 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4539 (domestic) or 1-847-619-6396 (international) and use passcode 47289344.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, August 1, 2018, beginning at 7:00 PM ET and will be accessible until Wednesday, August 8, 2018, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 47289344.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
[email protected]

 

SOURCE Vanda Pharmaceuticals Inc.


These press releases may also interest you

at 09:52
Zoomlion Shines at INTERMAT 2024 with a Vision for a Greener, Smarter Future
Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion", 01157.HK) proudly showcased its latest advancements at INTERMAT, held at the Nord Villepinte Exhibition Center in Paris from April 24-27, 2024. Themed "Greener Development, Brighter...

at 09:50
Exegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-037, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head Control and Sitting Without External Assistance
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...

at 09:49
4Pro (2nd Gen): A new generation of Pioneering Smart Commuting Solutions
Electric Scooter, 4Pro (2nd Gen), which is produced by Brightway Innovation Intelligent Technology (Suzhou) Co.,Ltd., is unveiled recently. Xiaomi Unveils 4Pro (2nd Gen) Xiaomi made waves with the unveiling of its latest Electric Scooter, 4Pro (2nd...

at 09:48
Oracle Introduces New AI Capabilities to Help Organizations Boost Sales
Oracle CloudWorld - Oracle today announced new artificial intelligence (AI) capabilities within Oracle Fusion Cloud Customer Experience (CX) to help marketers, sellers, and service agents accelerate deal cycles. The new AI capabilities will help...

at 09:47
BioAro Announces a Medical and Computing Breakthrough by Launching the 'World's Fastest' Real-Time Genomic Software 'PanOmiQ'
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...

at 09:46
AVL Establishes New Canadian Entity in Ontario
AVL, the global mobility technology company for development, simulation, and testing, has established a new entity to serve Canada's emerging battery technology and vehicle electrification sectors....

More news about Science and technology...


News published on and distributed by: